tadalafil has been researched along with Hypoxia in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Enomoto, N; Ikeda, T; Katsuragi, S; Maki, S; Nii, M; Takakura, S; Tanaka, H; Tanaka, K; Toriyabe, K; Tsuchiya, K | 1 |
| Endoh, M; Furuhashi, F; Hosoda, H; Ikeda, T; Ikemura, K; Kamimoto, Y; Kaneda, MK; Kato, I; Kimura, T; Kondo, E; Ma, N; Magawa, S; Maki, S; Miyoshi, T; Nii, M; Okuda, M; Owa, T; Shimada, K; Tachibana, R; Tanaka, H; Tanaka, K; Tsuji, M; Umekawa, T; Yoshikawa, K | 1 |
| Artigiane-Neto, R; Fujiki, RTM; Martins, JL; Mismetti, MM; Montero, EFS; Souza, CM; Souza, CVCP; Teixeira, LC | 1 |
| Domen, T; Imamura, T; Ishizuka, O; Minagawa, T; Nagai, T; Ogawa, T; Suzuki, T; Ueno, M | 1 |
| Altamura, S; Bärtsch, P; Dehnert, C; Maggiorini, M; Mairbäurl, H; Muckenthaler, MU; Theurl, I; Weiss, G | 1 |
| Gozal, D; Lei, Z; Nozdrachev, AD; Rao, CV; Shah, ZA; Soukhova-O'Hare, GK | 1 |
| Fahim, M; Kotwani, A; Rashid, M | 2 |
| Brown, JW; Fiore, AC; Meldrum, DR; Sheridan, BC; Tsai, BM; Turrentine, MW; Wang, M | 1 |
9 other study(ies) available for tadalafil and Hypoxia
| Article | Year |
|---|---|
Tadalafil Treatment Ameliorates Hypoxia and Alters Placental Expression of Proteins Downstream of mTOR Signaling in Fetal Growth Restriction.
Topics: Female; Fetal Growth Retardation; Humans; Hypoxia; Pregnancy; Sirolimus; Tadalafil; TOR Serine-Threonine Kinases | 2020 |
Tadalafil treatment in mice for preeclampsia with fetal growth restriction has neuro-benefic effects in offspring through modulating prenatal hypoxic conditions.
Topics: Animals; Basic Helix-Loop-Helix Transcription Factors; Brain; Disease Models, Animal; Female; Fetal Growth Retardation; Hypoxia; Mice; Placenta; Pre-Eclampsia; Pregnancy; Tadalafil; Treatment Outcome; Vasodilator Agents | 2019 |
Oxidative stress assessment in intestine of newborn rats submitted to hypoxia and reoxygenation with tadalafil.
Topics: Animals; Animals, Newborn; Female; Humans; Hypoxia; Intestinal Mucosa; Lipid Peroxidation; Malondialdehyde; Nitrates; Nitrites; Oxidative Stress; Oxygen; Phosphodiesterase 5 Inhibitors; Pregnancy; Random Allocation; Rats, Wistar; Reproducibility of Results; Tadalafil; Time Factors | 2019 |
Nicotine-induced hypoxia in rat urothelium deteriorates bladder storage functions.
Topics: Animals; Aquaporin 3; Female; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Nicotine; Rats; Rats, Sprague-Dawley; Tadalafil; Urinary Bladder; Urination; Uroplakin III; Urothelium | 2019 |
Increased hepcidin levels in high-altitude pulmonary edema.
Topics: Altitude; Altitude Sickness; Arterial Pressure; Carbolines; Dexamethasone; Hepcidins; Humans; Hypertension, Pulmonary; Hypoxia; Interleukin-6; Iron; Lung; Tadalafil; Vasoconstriction | 2015 |
Erectile dysfunction in a murine model of sleep apnea.
Topics: Animals; Blotting, Western; Carbolines; Comorbidity; Disease Models, Animal; Erectile Dysfunction; Estradiol; Hypoxia; Immunohistochemistry; Libido; Male; Mice; Mice, Inbred C57BL; Nitric Oxide Synthase; Penis; Phosphodiesterase Inhibitors; Sleep Apnea, Obstructive; Tadalafil; Testosterone | 2008 |
Long-acting phosphodiesterase 5 inhibitor, tadalafil, and superoxide dismutase mimetic, tempol, protect against acute hypoxia-induced pulmonary hypertension in rats.
Topics: Animals; Antioxidants; Blood Pressure; Carbolines; Cardiac Output; Cyclic N-Oxides; Heart Rate; Heart Ventricles; Hypertension, Pulmonary; Hypoxia; Malondialdehyde; Oxidative Stress; Phosphodiesterase 5 Inhibitors; Rats; Rats, Wistar; Spin Labels; Tadalafil; Vasodilation | 2012 |
Efficacy of tadalafil in chronic hypobaric hypoxia-induced pulmonary hypertension: possible mechanisms.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Carbolines; Cyclic N-Oxides; Disease Models, Animal; Glutathione; Hypertension, Pulmonary; Hypoxia; Inflammation; Lung; Malondialdehyde; Oxidative Stress; Phosphodiesterase 5 Inhibitors; Rats; Rats, Wistar; Spin Labels; Superoxide Dismutase; Tadalafil; Tumor Necrosis Factor-alpha; Ventricular Pressure | 2013 |
Differential effects of phosphodiesterase-5 inhibitors on hypoxic pulmonary vasoconstriction and pulmonary artery cytokine expression.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Drug Evaluation, Preclinical; Gene Expression Regulation; Hypertension, Pulmonary; Hypoxia; Imidazoles; Interleukin-1; Isometric Contraction; Male; Phenylephrine; Phosphodiesterase Inhibitors; Piperazines; Pulmonary Artery; Purines; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Tumor Necrosis Factor-alpha; Vardenafil Dihydrochloride; Vasoconstriction | 2006 |